Microdosing of psychedelics, particularly LSD, has garnered attention for its potential therapeutic benefits in psychiatric conditions like ADHD. Despite the belief that LSD may enhance cognitive flexibility and executive function, its effectiveness in treating ADHD symptoms remains uncertain.
A recent phase 2A clinical trial conducted at the University Hospital in Basel, Switzerland, and Maastricht University in the Netherlands aimed to address this issue. The study, published in JAMA, assessed the safety and efficacy of low-dose LSD in adults with ADHD, ultimately finding that while LSD administration was safe, it did not lead to a significant reduction in ADHD symptoms compared to a placebo. These findings underscore the need for further research into alternative ADHD treatments and highlight the importance of evidence-based practice in the field of psychedelic medicine.
Read more from medicaldialogues.in